Subscribe to our blog

Bluecrux sets out its vision for greater QC involvement in E2E planning

posted by
Adam Lester-George
Content Specialist @ Binocs

Bluecrux co-founder and EVP for Binocs, Geert Vanhove, has recently published an article on the company’s website outlining its vision for “handshake integration”. This novel approach to digitalizing the interaction between pharmaceutical Quality teams and wider Manufacturing and Supply Chain stakeholders is expected to significantly reduce end-to-end lead times and facilitate greater contributions by QC in overall planning processes.

Key takeaways

  • Quality teams represent a critical stage in the product release process but are rarely involved in S&OP discussions, despite accounting for up to 55% of end-to-end lead times
  • Evidence demonstrates that lead time savings can be achieved by improving the interaction between Quality operations and other key stakeholders, such as Manufacturing and Supply Chain
  • Bluecrux has developed a digital solution that allows APS, QC scheduling, and digital supply chain twin technologies to interface and facilitate dynamic, priority-based lead times to be automatically recalculated for exceptions

Handshake integration

Handshake integration would see a cross-platform offering from Bluecrux, including a comprehensive package that combines the company’s Consulting services with Binocs scheduling, our sister digital supply chain twin solution, Axon, and existing APS products. Together, this will provide pharmaceutical manufacturing clients with a digitally enabled, integrated planning solution that will automate many of the batch release processes that typically involve lengthy back-and-forth negotiations. Rather than all batches of the same type being assigned standard, fixed QC lead times, this approach will allow variable lead times to be calculated based on batch priority and QC availability. This dynamic approach is expected to complement the fixed Goods Receipt Processing Time that Supply Chain operatives currently rely on as the primary metric for formulating delivery expectations, allowing for a more flexible end-to-end planning process.

Additionally, it is hoped that implementing this process will facilitate greater direct communication between product release stakeholders and encourage greater involvement of Quality personnel in S&OP decision making processes.

If you’re interested in a first look at what Binocs can offer as part of a wider Bluecrux offering, why not check out Geert’s article for a more detailed exploration of the topic? If this is something you’d like to discuss further with us, feel free to reach out today!

Let’s have a chat

Check out some other articles and posts

  • A diagram illustrating the complex interaction between pharmaceutical manufacturing and Quality Control, highlighting how a single production batch can be tested as part of multiple campaigns that each include samples from multiple batches

    Handshake integration: bringing Quality into end-to-end decision making

    Introducing “handshake integration”, Bluecrux’s digitally enabled approach to improving lead times across the entire E2E flow and enhancing communication between pharma manufacturing stakeholders.
    Read more
  • Collaboratively Planning Quality-Control Laboratories with Binocs

    QC Laboratories Planning, which is what? Today, QC labs have to be lean labs. While coping with complexity and volatile demand, QC labs are constantly asked to increase analyst…
    Read more
  • Planning Your QC Lab with APS Software: is it a Good Idea?

    Planning production is different from planning a quality control lab. Here are a few things to consider before implementing APS software in a QC lab.
    Read more